Sponsor:
David Marcinek
Code:
NCT07275424
Conditions
Aging, Healthy
Eligibility Criteria
Sex: All
Age: 65 - 70+
Healthy Volunteers: Accepted
Interventions
Elamipretide will be supplied as a sterile 5.0 mL single-patient, multi-dose glass vial containing 3.75 mL of elamipretide solution (elamipretide [80 mg/mL], phosphate buffer, and benzyl alcohol)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-26. This information was provided to ClinicalTrials.gov by David Marcinek on 2025-12-10.